ICU Medical (NASDAQ:ICUI) Upgraded by Jefferies Financial Group to Buy Rating

ICU Medical (NASDAQ:ICUI) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Marketbeat.com reports. The firm currently has a $200.00 price target on the medical instruments supplier’s stock. Jefferies Financial Group’s price objective would suggest a potential upside of 24.91% from the company’s current price.

Several other analysts have also recently commented on ICUI. Raymond James lifted their target price on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. KeyCorp upped their target price on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $177.25.

ICU Medical Stock Performance

Shares of NASDAQ ICUI opened at $160.11 on Wednesday. The company has a 50-day simple moving average of $171.99 and a 200-day simple moving average of $150.34. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The company has a market cap of $3.92 billion, a PE ratio of -35.03 and a beta of 0.62. ICU Medical has a 12 month low of $83.26 and a 12 month high of $196.26.

Insider Activity

In related news, COO Christian B. Voigtlander sold 1,962 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $169.08, for a total value of $331,734.96. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director David C. Greenberg sold 972 shares of ICU Medical stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total transaction of $153,682.92. Following the transaction, the director now directly owns 5,037 shares in the company, valued at approximately $796,400.07. This trade represents a 16.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 40,364 shares of company stock valued at $6,869,878 in the last ninety days. Company insiders own 6.70% of the company’s stock.

Institutional Investors Weigh In On ICU Medical

Several large investors have recently made changes to their positions in ICUI. CWM LLC boosted its position in ICU Medical by 18.5% during the 2nd quarter. CWM LLC now owns 767 shares of the medical instruments supplier’s stock worth $91,000 after purchasing an additional 120 shares during the period. SG Americas Securities LLC grew its stake in shares of ICU Medical by 441.7% in the second quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier’s stock valued at $691,000 after buying an additional 4,744 shares in the last quarter. Blue Trust Inc. raised its holdings in shares of ICU Medical by 384.4% during the 2nd quarter. Blue Trust Inc. now owns 1,090 shares of the medical instruments supplier’s stock valued at $129,000 after buying an additional 865 shares during the period. Nisa Investment Advisors LLC lifted its position in ICU Medical by 3.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 10,939 shares of the medical instruments supplier’s stock worth $1,299,000 after acquiring an additional 339 shares in the last quarter. Finally, Kirr Marbach & Co. LLC IN boosted its holdings in ICU Medical by 5.6% in the 2nd quarter. Kirr Marbach & Co. LLC IN now owns 23,809 shares of the medical instruments supplier’s stock worth $2,827,000 after acquiring an additional 1,269 shares during the period. Institutional investors and hedge funds own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.